Back to Dashboard$2.1B annual revenue (47% of Apex total)$1.8B combined annual revenueEst. $45-80M additional cost per drug$890M annual revenue$50M small business ESOP formation fund
MedTech Innovation Coalition
Medical DevicesCompanion DiagnosticsDigital Health
18 provisions tracked
5 positive
6 negative
IndirectSec. CMS-2027-01 · CMS Medicare Drug Price Negotiation — 2027 Expansion
Nexavar-X (Sorafenib Extended-Release) — Oncology Biologic
Companion diagnostic for Nexavar-X (OncoDx Panel) may see reduced demand if therapy adoption declines post-negotiation.
IndirectSec. CMS-2027-02 · CMS Medicare Drug Price Negotiation — 2027 Expansion
Immunara / Immunara-SC — Autoimmune Biologics
Autoimmune diagnostic panels linked to Immunara prescribing — reduced therapy use impacts companion dx revenue.
IndirectSec. FDA-2026-AR · FDA Regulatory Reform
FDA Accelerated Approval Reform — Post-Market Evidence Requirements
New patient registry framework for RWE collection creates opportunities for MedTech diagnostic and monitoring platforms.
PositiveSec. CMS-2027-04 · CMS Medicare Drug Price Negotiation — 2027 Expansion
NeuroCalm XR — CNS / Psychiatric Medication
Digital therapeutic companion for NeuroCalm may see increased adoption as CMS seeks value-based alternatives.
PositiveSec. IRA-ESOP · Legislative — Tax/Employment
Retirement Security Enhancement Act — ESOP Expansion Impact on Health Sector
MedTech startups eligible for ESOP tax credits — helps with talent retention in competitive hiring market.